ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.040
+0.075 (7.76%)
At close: Aug 25, 2026, 4:00 PM EDT
1.032
-0.008 (-0.79%)
After-hours: Aug 25, 2026, 7:30 PM EDT

ADC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
219.11261.34250.87278.6326.44466.54
Cash & Short-Term Investments
219.11261.34250.87278.6326.44466.54
Cash Growth
-17.18%4.17%-9.95%-14.66%-30.03%6.23%
Accounts Receivable
28.0429.1220.3225.1872.9730.22
Other Receivables
-----1.93
Receivables
28.0429.1220.3225.1872.9732.14
Inventory
4.934.182.2516.1812.0711.12
Prepaid Expenses
5.385.618.3710.3423.515.35
Other Current Assets
4.256.089.455.99-0.02
Total Current Assets
261.71306.34291.25336.29434.98525.18
Property, Plant & Equipment
1.11.313.4316.1310.2611.23
Long-Term Investments
---1.657.6141.24
Other Intangible Assets
-----12.95
Long-Term Deferred Tax Assets
----37.126.05
Long-Term Deferred Charges
-----0.63
Other Long-Term Assets
16.5715.5217.30.710.90.69
Total Assets
279.38323.15321.98354.78490.86617.97

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12.769.1818.0315.5712.3512.08
Accrued Expenses
41.7643.3449.8239.1451.9337.77
Current Portion of Long-Term Debt
27.273---13.39
Current Portion of Leases
-0.541.371.471.11.03
Current Income Taxes Payable
-----3.75
Other Current Liabilities
4.5514.1111.2511.516.565.92
Total Current Liabilities
86.3370.1680.4767.6781.9473.94
Long-Term Debt
409.98434.98433.73416.3322.07305.82
Long-Term Leases
0.951.03810.186.566.99
Long-Term Unearned Revenue
-----23.54
Pension & Post-Retirement Benefits
-1.941.971.190.053.65
Other Long-Term Liabilities
10.330.870.477.690.7937.95
Total Liabilities
507.58508.98524.62503.03411.41451.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11.2511.088.437.317.316.45
Additional Paid-In Capital
1,4471,4401,2841,1811,166981.83
Retained Earnings
-1,685-1,636-1,493-1,335-1,095-924.89
Treasury Stock
-0.21-0.21-0.22-0.54-0.68-0.13
Comprehensive Income & Other
-0.81-0.52-1.42-0.091.82102.83
Shareholders' Equity
-228.21-185.83-202.64-148.2579.45166.09
Total Liabilities & Equity
279.38323.15321.98354.78490.86617.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
438.19439.55443.09427.95329.73327.23
Net Cash (Debt)
-219.08-178.21-192.22-149.35-3.29139.32
Net Cash Growth
------64.94%
Net Cash Per Share
-1.47-1.40-1.98-1.83-0.041.82
Filing Date Shares Outstanding
127.67127.0499.0882.5380.6476.81
Total Common Shares Outstanding
127.44125.7598.8682.2980.6476.81
Working Capital
175.38236.17210.79268.62353.04451.25
Book Value Per Share
-1.79-1.48-2.05-1.800.992.16
Tangible Book Value
-228.21-185.83-202.64-148.2579.45153.14
Tangible Book Value Per Share
-1.79-1.48-2.05-1.800.991.99
Machinery
-1.166.525.944.684.15
Leasehold Improvements
-0.233.873.952.082.25
SEC Filings: 10-K · 10-Q